Urology News and Research

Latest Urology News and Research

Androgen deprivation therapy interferes with diabetes control

Androgen deprivation therapy for prostate cancer hampers glycemic control in men with diabetes, report researchers.

5 Mar 2013

Mirabegron reduces frequency of incontinence episodes in phase III trial

In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with overactive bladder compared to those in a placebo group.

5 Mar 2013

Registration open for Society of Interventional Radiology's Annual Scientific Meeting

Online meeting registration is open for the Society of Interventional Radiology's Annual Scientific Meeting April 13 at the Ernest N. Morial Convention Center in New Orleans.

1 Mar 2013

Study shows how theranostic nanoparticles can effectively deliver cancer drugs to tumour cells

Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.

1 Mar 2013

First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients

The March 2013 issue of The Journal of Urology, the official journal of The American Urological Association, includes a study conducted by four physicians from Radiotherapy Clinics of Georgia (RCOG), a Vantage Oncology affiliate.

28 Feb 2013

Research shows many cancers can be prevented with healthy lifestyle choices

Each year more individuals worldwide die from cancer than malaria, tuberculosis and HIV combined. With research showing that many cancers can be prevented with healthy lifestyle choices, Seattle Cancer Care Alliance is working to raise awareness of preventive tactics in honor of National Cancer Prevention Month.

27 Feb 2013

Follow up evaluations necessary for 15 years after radiation therapy for prostate cancer patients

27 Feb 2013

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

Taiho Pharmaceutical Co., Ltd. announced on February 27 that it submitted an application on February 26 for approval of the manufacture and marketing of the novel oral nucleoside antitumor agent TAS-102 (combination of trifluorothymidine (FTD) and tipiracil hydrochloride (TPI)) to the Japanese Ministry of Health, Labor and Welfare.

27 Feb 2013

‘Traffic light’ guide for pediatric bacterial infection needs refining

Study results suggest that a “traffic light” system for categorizing the severity of infections in children fails to detect a substantial number of serious bacterial infections, particularly urinary tract infections.

26 Feb 2013

FDA approves Actavis’ generic Suboxone ANDA to treat opioid dependence

Actavis, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone.

26 Feb 2013

Screening of children with LUT dysfunction needs refining

Physicians should include screening for psychosocial comorbidities and obesity when evaluating children with lower urinary tract dysfunction, say researchers.

25 Feb 2013

Greek and Spanish patients can now read EAU Patient Information in their native language

Greek and Spanish-speaking patients with kidney or ureteral stones can now read EAU Patient Information in their native language. The Endourology, Laparoscopy and Urotechnology Section of the Hellenic Urologic Association (HUA) has provided the Greek translation and the Spanish translation is the result of a collaboration between the Spanish Association of Urology (AEU) and the Dominican Republic Society of Urology (SDU).

25 Feb 2013

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, today announced that the World Health Organization (WHO) has approved the international nonproprietary name (INN) “auriclosene” (pronounced awr-rih-CLO-zeen) for the Company’s lead Aganocide® compound NVC-422.

21 Feb 2013

GCP could help lengthen life expectancy of certain prostate cancer patients

A natural, nontoxic product called genistein-combined polysaccharide, or GCP, which is commercially available in health stores, could help lengthen the life expectancy of certain prostate cancer patients, UC Davis researchers have found.

21 Feb 2013

Predictive value of prostate cancer gene 3 validated

Researchers have confirmed that the prostate cancer gene 3 is a valid predictor for current cancer and future biopsy outcomes.

20 Feb 2013

Experts identify new gene responsible for spinal meningioma

Genetic medicine experts from Manchester Biomedical Research Centre at Saint Mary's Hospital and The University of Manchester have identified a new gene responsible for causing an inherited form of tumour, known as spinal meningioma.

From The University of Manchester 19 Feb 2013

New regeneration approach could be used for people with bladder issues

A new approach to bladder regeneration is capitalizing on the potential of two distinct cell populations harvested from a patient's healthy bone marrow, a new study reports.

19 Feb 2013

Antimuscarinic effective for overactive bladder in elderly

The antimuscarinic drug fesoterodine seems to be an effective and well-tolerated treatment for elderly individuals with an overactive bladder, including those older than 75 years, show findings from a clinical trial.

19 Feb 2013

MicroRNAs hold promise as markers for bladder cancer prognosis

Researchers have found that microRNAs can be useful prognostic biomarkers for individuals with urothelial carcinoma.

18 Feb 2013

CARHY successfully conducts urology surgery through HOLEP 100 watt laser technique

Columbia Asia Referral Hospital, Yeshwanthpur (CARHY) successfully conducted a Urology surgery through an advanced laser technology - HOLEP. The team of doctors led by Dr Manohar, Consultant Urologist at CARHY removed a large prostate gland weighing 350 gms, hitherto unheard of in medical history.

18 Feb 2013

Urology News and Research

Latest Urology News and Research

Androgen deprivation therapy interferes with diabetes control

Mirabegron reduces frequency of incontinence episodes in phase III trial

Registration open for Society of Interventional Radiology's Annual Scientific Meeting

Study shows how theranostic nanoparticles can effectively deliver cancer drugs to tumour cells

First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients

Research shows many cancers can be prevented with healthy lifestyle choices

Follow up evaluations necessary for 15 years after radiation therapy for prostate cancer patients

Taiho Pharmaceutical seeks Japanese approval for TAS-102 to treat colorectal cancer

‘Traffic light’ guide for pediatric bacterial infection needs refining

FDA approves Actavis’ generic Suboxone ANDA to treat opioid dependence

Screening of children with LUT dysfunction needs refining

Greek and Spanish patients can now read EAU Patient Information in their native language

International nonproprietary name “auriclosene” approved by WHO for NovaBay’s NVC-422

GCP could help lengthen life expectancy of certain prostate cancer patients

Predictive value of prostate cancer gene 3 validated

Experts identify new gene responsible for spinal meningioma

New regeneration approach could be used for people with bladder issues

Antimuscarinic effective for overactive bladder in elderly

MicroRNAs hold promise as markers for bladder cancer prognosis

CARHY successfully conducts urology surgery through HOLEP 100 watt laser technique

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Urology News and Research

Latest Urology News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in